We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $418.00. The company’s shares closed ...

BUCHAREST, Jan 14 (Reuters) - A Romanian court lifted a house arrest order against internet personality Andrew Tate, replacing it with a lighter preventative measure pending the outcome of a ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled ...

AVDL opened at $7.90 on Thursday. The firm has a 50 day moving average price of $11.41 and a 200 day moving average price of $13.54. The company has a market cap of $761.26 million, a PE ratio of ...

In the latest market close, Vertex Pharmaceuticals (VRTX) reached $409.56, with a -0.62% movement compared to the previous day. This change was narrower than the S&P 500's 1.54% loss on the day.

Ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) were provided by 23 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise ...

Jan 8 (Reuters) - AVITA Medical's Australia-listed shares sank nearly 19% on Wednesday, set for their worst day in 15 months, after the regenerative medicine firm cut its forecast for the fourth ...

Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price trimmed by Sanford C. Bernstein from $314.00 to $310.00 in a research report report published on Tuesday morning ...

The monarch, 76, has increasingly sought to distance himself from Andrew, cutting him off financially and pressuring him to skip the royal family's Christmas celebrations in December. That all ...